H. Hochkeppel

H. Hochkeppel, J. Johnson, J. D. Gangemi, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

MX HOMOLOGOUS PROTEIN IN MONONUCLEAR CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

H. Hochkeppel, H. Deicher, K. Hartung, 1989, Arthritis and rheumatism.

Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis

C. Wolz, H. Hochkeppel, M. Ranke, 1988, Journal of clinical microbiology.

Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8

E. Kaplan, H. Hochkeppel, A. Boutonnier, 1987, Journal of clinical microbiology.

IFN-αInduced Human 78 kD Protein: Purification and Homologies with the Mouse Mx Protein, Production of Monoclonal Antibodies, and Potentiation Effect of IFN-γ

H. Hochkeppel, M. Horisberger, 1987 .

Monoclonal antibodies against human fibroblast interferon

H. Hochkeppel, J. Collins, U. Menge, 1981, Nature.

The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection.

H. Hochkeppel, I. Schedel, H. Deicher, 1990, AIDS.

Transformation-Related Cellular Protein p53: Increased Level in Untransformed Rat Cells Following Treatment with the Tumorpromoter, Tetradecanoylphorbol-Acetate

G. Brandner, H. Hochkeppel, D. Braun, 1986, Zeitschrift fur Naturforschung. C, Journal of biosciences.

MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon.

H. Hochkeppel, O. Haller, A. Hovanessian, 1994, The Journal of infectious diseases.

Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma.

H. Hochkeppel, H. Deicher, P. von Wussow, 1990, The Journal of investigative dermatology.

Emergence and decay of the human Mx homolog in cancer patients during and after interferon-alpha therapy.

H. Hochkeppel, H. Deicher, P. von Wussow, 1990, Journal of biological response modifiers.

9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections

E. De Clercq, R. Cozens, H. Hochkeppel, 1989, Antimicrobial Agents and Chemotherapy.

Identification of novel mdm2 binding peptides by phage display.

D. Lane, C. García-echeverría, P. Chène, 1996, Oncogene.

Antagonism of interferon induction in spleen and adherent peritoneal cells of mice by the lipophilic antiviral muramyl peptide MTP-PE.

H. Hochkeppel, M. Walker, F. Dietrich, 1986, Journal of Interferon Research.

Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide--I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs.

H. Hochkeppel, F. Dietrich, B. Lukas, 1986, International journal of immunopharmacology.

Monoclonal antibody against human IFN-γ

H. Hochkeppel, M. Ley, 1982, Nature.

Links between effects of butyrate on histone hyperacetylation and regulation of interferon synthesis in Namalva and FS-4 cell lines.

H. Hochkeppel, J. Bode, K. Maass, 1982, Journal of interferon research.

An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies.

H. Hochkeppel, M. Horisberger, 1985, The Journal of biological chemistry.

Treatment of anti‐recombinant interferon‐alpha 2 antibody positive CML patients with natural interferon‐alpha

H. Hochkeppel, H. Deicher, R. Hehlmann, 1991, British journal of haematology.

Antiviral activity of a novel recombinant human interferon-αB/D hybrid

H. Hochkeppel, A. Matter, F. Dietrich, 1989 .

Strong transient expression of the type I interferon–induced MxA protein in hepatitis A but not in acute hepatitis B and C

H. Hochkeppel, H. Deicher, P. von Wussow, 1994, Hepatology.

The effect of recombinant human interferon α BD compared to interferon α 2b on SIV infection in rhesus macaques

J. Heeney, H. Hochkeppel, H. Niphuis, 1996 .

Effective Natural Interferon-a Therapy in Recombinant Interferon-a-Resistant Patients With Hairy Cell Leukemia

H. Hochkeppel, H. Pralle, D. Jakschies, 2003 .

Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia.

T. Haferlach, H. Hochkeppel, H. Pralle, 1991, Blood.

Evidence for cross-linking of polyribonucleotides with 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride.

H. Hochkeppel, J. Gordon, 1979, Biochemistry.

Inducibility of human β-interferon gene in mouse L-cell clones

H. Hauser, H. Hochkeppel, U. Mayr, 1982, Nature.

REGULATION OF THE HUMAN INTERFERON ß GENE IN MOUSE L CELL CLONES AND IN HUMAN CELLS

H. Hauser, H. Hochkeppel, U. Mayr, 1982 .

Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections.

H. Hochkeppel, J. D. Gangemi, B. Poncioni, 1989, Journal of interferon research.

A method of preparing Escherichia coli 16 S RNA possessing previously unobserved 30 S ribosomal protein binding sites.

H. Hochkeppel, E. Spicer, G. Craven, 1976, Journal of molecular biology.

Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.

H. Hochkeppel, A. Matter, F. Dietrich, 1989, Journal of interferon research.

Significant changes in 16 S RNA conformation accompanying assembly of the 30 S ribosome in vitro.

H. Hochkeppel, G. Craven, 1977, Journal of molecular biology.

Preparation-sensitive conformations in ribosomal RNAs

H. Hochkeppel, J. Gordon, 1978, Nature.

RNA of the small subunit of the Escherichia coli ribosome With additional protein binding sites Characterization of the structure by electron micro

H. Hochkeppel, J. Gordon, C. Brack, 1977, FEBS letters.

Evidence that 16S RNA from E. coli can assume two different biologically active conformations.

H. Hochkeppel, G. Craven, 1976, Nucleic acids research.

Monoclonal antibodies to the multienzyme enniatin synthetase. Production and use in structural studies.

H. Hochkeppel, D. Lavanchy, A. Billich, 1987, Biological chemistry Hoppe-Seyler.

Early Viral Proteins As Autoantigens

C. Ryschkewitsch, H. Hochkeppel, D. Walker, 1988 .

Antiviral and antiproliferative effects of interferons delivered via monoclonal antibodies.

H. Hochkeppel, S. Alkan, D. Braun, 1984, Journal of interferon research.

Further evidence that the ribosomal 30S proteins S3, S5, S9, S11, S12, and S18 possess specific 16S RNA binding sites

H. Hochkeppel, G. Craven, 1977, Molecular and General Genetics MGG.

IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma.

H. Hochkeppel, M. Horisberger, 1987, Journal of interferon research.

Cross‐Species Antiviral Activity of a Recombinant Human Alpha‐Interferon Hybrid a

H. Hochkeppel, S. Pyo, E. Mayer, 1992, Annals of the New York Academy of Sciences.

Biological activities of human recombinant interferon α/β targeted by anti‐Epstein‐Barr virus monoclonal antibodies

H. Hochkeppel, S. Alkan, D. Braun, 1985 .